Castle Biosciences Inc SEC filings CSTL

Castle Biosciences Inc has 890 filings in SEC EDGAR's recent list, going back to Oct 2, 2008. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Castle Biosciences Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 2, 2026 —
4 Insider transaction Oct 30, 2026 Oct 28, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 29, 2026 —
4 Insider transaction Oct 28, 2026 Oct 26, 2026
4 Insider transaction Oct 21, 2026 Oct 19, 2026
4 Insider transaction Oct 14, 2026 Oct 12, 2026
144 Notice of proposed sale Oct 13, 2026 —
4 Insider transaction Oct 7, 2026 Oct 5, 2026
144 Notice of proposed sale Oct 5, 2026 —
4 Insider transaction Oct 5, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Oct 1, 2026 Sep 29, 2026
4 Insider transaction Sep 23, 2026 Sep 21, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 15, 2026 Sep 11, 2026
144 Notice of proposed sale Sep 14, 2026 —
144 Notice of proposed sale Sep 11, 2026 —
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Aug 27, 2026 Aug 25, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
CERT Filing Aug 17, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
144 Notice of proposed sale Aug 14, 2026 —
8-A12B Filing Aug 14, 2026 —
4 Insider transaction Aug 6, 2026 Nov 24, 2025
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
4 Insider transaction Aug 4, 2026 Jul 31, 2026
144 Notice of proposed sale Jul 31, 2026 —
144 Notice of proposed sale Jul 31, 2026 —
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 30, 2026 Jul 30, 2026
4 Insider transaction Jul 29, 2026 Jul 27, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 3, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
8-K Current report
Shareholder vote results
May 29, 2026 May 28, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 27, 2026 May 22, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 22, 2026 May 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 11, 2026 May 7, 2026
144 Notice of proposed sale May 7, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2026 May 6, 2026
4 Insider transaction Apr 23, 2026 Apr 21, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
ARS Annual report to shareholders Apr 8, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 8, 2026 —
DEF 14A Proxy statement Apr 8, 2026 May 28, 2026
4 Insider transaction Mar 30, 2026 Mar 26, 2026
4 Insider transaction Mar 30, 2026 Mar 26, 2026
144 Notice of proposed sale Mar 26, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
144 Notice of proposed sale Mar 12, 2026 —
144 Notice of proposed sale Mar 11, 2026 —
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 5, 2026 Feb 3, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2026 Jan 11, 2026
4 Insider transaction Jan 7, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Dec 29, 2025 Dec 22, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 15, 2025 Dec 11, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
144 Notice of proposed sale Dec 11, 2025 —
144 Notice of proposed sale Dec 11, 2025 —
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 26, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
4 Insider transaction Nov 24, 2025 Nov 20, 2025
4 Insider transaction Nov 20, 2025 Nov 18, 2025
4/A Form 4/a Nov 14, 2025 Nov 11, 2025
4 Insider transaction Nov 13, 2025 Nov 11, 2025
4 Insider transaction Nov 13, 2025 Nov 11, 2025
4 Insider transaction Nov 13, 2025 Nov 11, 2025
144 Notice of proposed sale Nov 12, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
4 Insider transaction Nov 6, 2025 Nov 4, 2025
4 Insider transaction Nov 4, 2025 Oct 31, 2025
4/A Form 4/a Nov 4, 2025 Aug 27, 2025
144 Notice of proposed sale Nov 4, 2025 —
S-8 Employee stock plan registration Nov 3, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 3, 2025 Nov 3, 2025
4 Insider transaction Oct 23, 2025 Oct 20, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 9, 2025 —
4 Insider transaction Oct 6, 2025 Oct 2, 2025
144 Notice of proposed sale Oct 2, 2025 —
4 Insider transaction Sep 19, 2025 Sep 17, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
4 Insider transaction Aug 29, 2025 Aug 27, 2025
144 Notice of proposed sale Aug 27, 2025 —
144 Notice of proposed sale Aug 27, 2025 —
4 Insider transaction Aug 19, 2025 Aug 15, 2025
144 Notice of proposed sale Aug 15, 2025 —
4 Insider transaction Aug 15, 2025 Aug 13, 2025
144 Notice of proposed sale Aug 13, 2025 —
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025
8-K Current report
Bylaw or fiscal year change
Aug 8, 2025 Aug 5, 2025
10-Q Quarterly report Aug 4, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2025 Aug 4, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
144 Notice of proposed sale Jun 27, 2025 —
4 Insider transaction May 23, 2025 May 21, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
May 23, 2025 May 22, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 12, 2025 May 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report May 5, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 5, 2025 May 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2025 —
4 Insider transaction Apr 23, 2025 Apr 21, 2025
SCHEDULE 13G Ownership over 5% (passive) Apr 14, 2025 —
4 Insider transaction Apr 10, 2025 Apr 8, 2025
ARS Annual report to shareholders Apr 9, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 9, 2025 —
DEF 14A Proxy statement Apr 9, 2025 May 22, 2025
144 Notice of proposed sale Apr 8, 2025 —
PRE 14A Preliminary proxy statement Mar 28, 2025 May 22, 2025
4 Insider transaction Mar 28, 2025 Mar 26, 2025
4 Insider transaction Mar 28, 2025 Mar 26, 2025
4/A Filing Mar 25, 2025 May 23, 2024
4/A Filing Mar 12, 2025 May 23, 2024
4 Insider transaction Mar 11, 2025 Mar 7, 2025
144 Notice of proposed sale Mar 7, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
CSTL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Friendswood, TX
SEC filer status
Accelerated filer
SEC CIK
1447362

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.